Gilead Sciences to Acquire Arcellx for $7.8B – Bolsters CAR‑T Pipeline with BCMA‑Targeted Anito‑cel
Gilead Sciences Inc. (NASDAQ: GILD) announced a definitive agreement to acquire Arcellx Inc. (NASDAQ: ACLX) for USD 115.00...
Deals
Findcure Bio Raises $14.5 Million Series B to Advance Radiopharmaceutical Platform
Fannkoer Biotech (Zhongshan) Co., Ltd. announced the completion of a Series B financing round exceeding...
Siemens Healthineers Deepens Mayo Clinic Partnership on AI Neurology and Precision Oncology
Siemens Healthineers AG (ETR: SHL) and Mayo Clinic announced an expansion of their strategic partnership, targeting...
VivaVision Biotech Files Hong Kong IPO to Advance Ophthalmology Pipeline
VivaVision Biotech (Zhejiang) Co., Ltd., an ophthalmology-focused biotech company founded in 2016, has submitted its...
Genhouse Bio Partners with Gilead on $1.5 Billion Synthetic Lethal Cancer Project GH31
Genhouse Bio (Suzhou) Co., Ltd., a Viva Biotech-incubated company, announced a global collaboration agreement with...
First Imaging Raises $14.5 Million to Advance AI-Powered Intraoperative Imaging
First Imaging, a Nantong-based medical imaging equipment provider, has closed a Series B+ financing round...
China Medical System Licenses Teikoku’s Lidoderm for Postherpetic Neuralgia in China
China Medical System Holdings Limited (HKG: 0867) announced a licensing agreement with Teikoku Seiyaku Co., Ltd.,...
Salubris Pharma Files Hong Kong IPO for Secondary Listing to Expand Cardiorenal Metabolic Franchise
Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294), a pioneer in cardiorenal metabolic syndrome treatment in China,...
Immunofoco Bio Files Hong Kong IPO for Solid Tumor CAR-T Pipeline
Shenzhen Immunofoco Biotechnology Co., Ltd., an innovative cell therapy developer, has submitted its IPO application...
Ribo Life Science Licenses $4.4 Billion MASH siRNA Portfolio to Madrigal Pharmaceuticals
Suzhou Ribo Life Science Co., Ltd. (HKG: 6938) has entered a landmark licensing agreement with Madrigal...
Novartis Secures Long-Term Actinium-225 Supply from Niowave for Radioligand Therapy Expansion
Novartis AG (NYSE: NVS) has entered a long-term supply agreement with Niowave Inc., a US-based isotope...
Therom Fisher’s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials
Thermo Fisher Scientific Inc. (NYSE: TMO) announced a strategic partnership between its PPD clinical research business...
Sanofi Invests $30 Million in GluBio’s Sickle Cell TPD Programs
GluBio Pharmaceutical Co., Ltd., a Zhejiang-based molecular glue targeted protein degradation (TPD) specialist, announced a...
Jingxin Pharmaceutical Files Hong Kong IPO for Dual Listing Strategy
Jingxin Pharmaceutical Co., Ltd. (SHE: 002020) has submitted its IPO prospectus to the Hong Kong Stock...
Guangji Pharma to Raise $87 Million via Private Placement to Controlling Shareholder
Hubei Guangji Pharmaceutical Co., Ltd. (SHE: 000952) announced plans for a private placement of up to...
uBriGene Biosciences Partners with BriSTAR Immunotech on Universal STAR-T Cell Therapy CDMO
uBriGene Biosciences, a China-based advanced therapy medicinal product (ATMP) CDMO, has entered a strategic partnership...
Newsoara BioPharma Expands Global Rights to vTv’s PDE4 Inhibitor HPP737 in $135 Million Deal
Newsoara BioPharma Co., Ltd. and vTv Therapeutics LLC have expanded their strategic collaboration, with Newsoara...
Siemens Healthineers Partners with Northwestern Medicine to Advance Precision Cancer Care
Siemens Healthineers AG (ETR: SHL) and Northwestern Medicine have officially launched the first phase of a...
Cascade Pharma Raises $72 Million to Advance MASH and Obesity Pipeline to Phase III
Cascade Pharmaceuticals, Inc., a Shanghai-based sino-foreign joint venture, has closed a RMB 500 million (USD 72.34 million)...
uBriGene Biosciences Partners with Innovec Biotherapeutics on AAV Gene Therapy for Hereditary Eye Diseases
uBriGene Biosciences, a China-based advanced therapy medicinal product (ATMP) CDMO, has entered a strategic partnership...